(Q37362752)

19 August 2017

1 reference

title

Does lowering cholesterol have an impact on the progression of aortic stenosis? (English)

1 reference

19 August 2017

0 references

Anders M Greve

1

1 reference

19 August 2017

Kristian Wachtell

series ordinal

2

1 reference

19 August 2017

language of work or name

1 reference

1 August 2008

1 reference

Therapeutic advances in cardiovascular disease

19 August 2017

published in

1 reference

19 August 2017

volume

2

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

277-286

1 reference

Adhesion molecules and atherosclerosis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Is aortic stenosis a preventable disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

21 January 2018

Acquired aortic stenosis

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Molecular genetics of aortic valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Natural history of aortic valve stenosis of varying severity in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Immunomodulation of the inflammatory response in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Comprehensive evaluation of preoperative patients with aortic valve stenosis: usefulness of cardiac multidetector computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

The natural history and rate of progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Approach to the patient with aortic stenosis and low ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Mechanisms of aortic valve calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Calcific aortic stenosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

The clinical relevance of low-density-lipoproteins size modulation by statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Antiatherosclerotic effects of statins: LDL versus non-LDL effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Flow dependence of valve area in aortic stenosis: relation to valve morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

A systematic review and economic evaluation of statins for the prevention of coronary events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Calcification of the aortic valve: its progression and grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Low density lipoprotein undergoes oxidation within lysosomes in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093935

21 January 2018

Identifiers

DOI

10.1177/1753944708093935

1 reference

19 August 2017

1 reference